Lichen International (LICN) Cash & Equivalents (2021 - 2025)

Lichen International (LICN) has 5 years of Cash & Equivalents data on file, last reported at $26.9 million in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $26.9 million, up 0.76% year-over-year; the trailing twelve-month figure through Dec 2025 was $26.9 million (up 0.76% YoY), and the FY2025 annual result was $26.9 million, up 0.76% from the prior year.
• Cash & Equivalents rose to $26.9 million in Q4 2025 per LICN's latest filing, from $22.6 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $26.9 million in Q4 2025 and troughed at $16.8 million in Q4 2021.
• A 5-year average of $23.3 million and a median of $24.2 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents jumped 37.44% in 2024, then decreased 12.7% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $16.8 million in 2021, then surged by 34.16% to $22.6 million in 2022, then climbed by 14.41% to $25.9 million in 2023, then rose by 3.31% to $26.7 million in 2024, then rose by 0.76% to $26.9 million in 2025.
• Business Quant data shows LICN's Cash & Equivalents at $26.9 million in Q4 2025, $22.6 million in Q2 2025, and $26.7 million in Q4 2024.